Minimally Invasive Treatments of the Thyroid
ConditionPapillary Thyroid Microcarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Institute of Oncology
About this trial
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)
Eligibility criteria
Qualifiers
Patients > 18years
Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.
Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
Patients must be accessible for follow-up
Disqualifiers
Tumors > 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders
Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study
Trial design
Treatments tested in this trial
- image-guided thermal ablation
Treatment groups
270 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov